Mutant xylanase, manufacturing method and use therefor, and method for manufacturing saccharified lignocellulose

US9567617B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9567617-B2
Application numberUS-201615042395-A
CountryUS
Kind codeB2
Filing dateFeb 12, 2016
Priority dateNov 25, 2011
Publication dateFeb 14, 2017
Grant dateFeb 14, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

What is aimed at is provision of an inexpensive and efficient saccharification method for lignocellulose using a thermostable xylanase and provision of a mutant xylanase that has a substitute amino acid residue, and that exhibits stable activity even under severe conditions in which enzymes easily inactivate, and that provides an initial rate of reaction not significantly reduced as compared to a wild-type xylanase corresponding to the mutant xylanase. Provided is a method of producing a saccharified product of lignocellulose, including contacting a lignocellulosic raw material with a thermostable xylanase, and a mutant xylanase that provides an initial rate of reaction that is at least 70% of that provided by a wild-type xylanase corresponding thereto, that has a xylanase activity after heat treatment at 50° C. for 24 hours that is at least 50% of its xylanase activity before the heat treatment, and that has a substitute amino acid residue.

First claim

Opening claim text (preview).

The invention claimed is: 1. A nucleic acid encoding a mutant xylanase, the mutant xylanase comprising the following amino acid residues substitutions in the amino acid sequence of SEQ ID NO: 1: a leucine residue substituted for an asparagine residue at position 29; an arginine residue substituted for a lysine residue at position 58; an amino acid residue, other than a tyrosine residue, substituted for a tyrosine residue at position 27; and an amino acid residue, other than an asparagine residue, substituted for an asparagine residue at position 44, or the mutant xylanase comprising 1 to 10 amino acid residues substitution in the amino acid sequence of SEQ ID NO: 1 in addition of the following amino acid residues substitutions: a leucine residue substituted for an asparagine residue at position 29, an arginine residue substituted for a lysine residue at position 58, a phenylalanine residue substituted for a tyrosine residue at position 27, and a serine residue substituted for an asparagine residue at position 44. 2. The nucleic acid according to claim 1 , wherein the amino acid residue, other than a tyrosine residue, substituted for the tyrosine residue at position 27 in the amino acid sequence of SEQ ID NO: 1 is a phenylalanine residue, and the amino acid residue, other than an asparagine residue, substituted for an asparagine residue at position 44 in the amino acid sequence of SEQ ID NO: 1 is a serine residue. 3. An expression vector comprising the nucleic acid according to claim 1 . 4. A transformant comprising the expression vector according to claim 3 . 5. The transformant according to claim 4 , wherein a host cell of the transformant is a cell obtained from Escherichia coli, Bacillus subtilis , yeast, an actinomycete, or a filamentous fungus. 6. The transformant according to claim 5 , wherein the filamentous fungus belongs to the genus Trichoderma , the genus Acremonium , the genus Humicola , or the genus Aspergillus. 7. The transformant according to claim 5 , wherein the filamentous fungus is Trichoderma viride, Acremonium cellulolyticus, Humicola insolens , or Aspergillus niger. 8. A method of producing a mutant xylanase, the method comprising culturing the transformant according to claim 4 and recovering the mutant xylanase from at least one of the cultured transformant or a culture product of the transformant.

Assignees

Inventors

Classifications

  • Biofuels, e.g. bio-diesel · CPC title

  • containing enzymes other than protease, amylase, lipase, cellulase, oxidase or reductase · CPC title

  • Cellulase (3.2.1.4), i.e. endo-1,4-beta-glucanase · CPC title

  • C12P19/02Primary

    Monosaccharides (2-ketogulonic acid C12P7/60) · CPC title

  • C12P19/14Primary

    produced by the action of a carbohydrase {(EC 3.2.x)}, e.g. by alpha-amylase {, e.g. by cellulase, hemicellulase} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9567617B2 cover?
What is aimed at is provision of an inexpensive and efficient saccharification method for lignocellulose using a thermostable xylanase and provision of a mutant xylanase that has a substitute amino acid residue, and that exhibits stable activity even under severe conditions in which enzymes easily inactivate, and that provides an initial rate of reaction not significantly reduced as compared to…
Who is the assignee on this patent?
Mitsui Chemicals Inc, Meiji Seika Pharma Co Ltd
What technology area does this patent fall under?
Primary CPC classification C12P19/02. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).